Microrna Expression in Rat Apical Periodontitis Bone Lesion
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Supplemental Information to Mammadova-Bach Et Al., “Laminin Α1 Orchestrates VEGFA Functions in the Ecosystem of Colorectal Carcinogenesis”
Supplemental information to Mammadova-Bach et al., “Laminin α1 orchestrates VEGFA functions in the ecosystem of colorectal carcinogenesis” Supplemental material and methods Cloning of the villin-LMα1 vector The plasmid pBS-villin-promoter containing the 3.5 Kb of the murine villin promoter, the first non coding exon, 5.5 kb of the first intron and 15 nucleotides of the second villin exon, was generated by S. Robine (Institut Curie, Paris, France). The EcoRI site in the multi cloning site was destroyed by fill in ligation with T4 polymerase according to the manufacturer`s instructions (New England Biolabs, Ozyme, Saint Quentin en Yvelines, France). Site directed mutagenesis (GeneEditor in vitro Site-Directed Mutagenesis system, Promega, Charbonnières-les-Bains, France) was then used to introduce a BsiWI site before the start codon of the villin coding sequence using the 5’ phosphorylated primer: 5’CCTTCTCCTCTAGGCTCGCGTACGATGACGTCGGACTTGCGG3’. A double strand annealed oligonucleotide, 5’GGCCGGACGCGTGAATTCGTCGACGC3’ and 5’GGCCGCGTCGACGAATTCACGC GTCC3’ containing restriction site for MluI, EcoRI and SalI were inserted in the NotI site (present in the multi cloning site), generating the plasmid pBS-villin-promoter-MES. The SV40 polyA region of the pEGFP plasmid (Clontech, Ozyme, Saint Quentin Yvelines, France) was amplified by PCR using primers 5’GGCGCCTCTAGATCATAATCAGCCATA3’ and 5’GGCGCCCTTAAGATACATTGATGAGTT3’ before subcloning into the pGEMTeasy vector (Promega, Charbonnières-les-Bains, France). After EcoRI digestion, the SV40 polyA fragment was purified with the NucleoSpin Extract II kit (Machery-Nagel, Hoerdt, France) and then subcloned into the EcoRI site of the plasmid pBS-villin-promoter-MES. Site directed mutagenesis was used to introduce a BsiWI site (5’ phosphorylated AGCGCAGGGAGCGGCGGCCGTACGATGCGCGGCAGCGGCACG3’) before the initiation codon and a MluI site (5’ phosphorylated 1 CCCGGGCCTGAGCCCTAAACGCGTGCCAGCCTCTGCCCTTGG3’) after the stop codon in the full length cDNA coding for the mouse LMα1 in the pCIS vector (kindly provided by P. -
Gene Symbol Gene Description ACVR1B Activin a Receptor, Type IB
Table S1. Kinase clones included in human kinase cDNA library for yeast two-hybrid screening Gene Symbol Gene Description ACVR1B activin A receptor, type IB ADCK2 aarF domain containing kinase 2 ADCK4 aarF domain containing kinase 4 AGK multiple substrate lipid kinase;MULK AK1 adenylate kinase 1 AK3 adenylate kinase 3 like 1 AK3L1 adenylate kinase 3 ALDH18A1 aldehyde dehydrogenase 18 family, member A1;ALDH18A1 ALK anaplastic lymphoma kinase (Ki-1) ALPK1 alpha-kinase 1 ALPK2 alpha-kinase 2 AMHR2 anti-Mullerian hormone receptor, type II ARAF v-raf murine sarcoma 3611 viral oncogene homolog 1 ARSG arylsulfatase G;ARSG AURKB aurora kinase B AURKC aurora kinase C BCKDK branched chain alpha-ketoacid dehydrogenase kinase BMPR1A bone morphogenetic protein receptor, type IA BMPR2 bone morphogenetic protein receptor, type II (serine/threonine kinase) BRAF v-raf murine sarcoma viral oncogene homolog B1 BRD3 bromodomain containing 3 BRD4 bromodomain containing 4 BTK Bruton agammaglobulinemia tyrosine kinase BUB1 BUB1 budding uninhibited by benzimidazoles 1 homolog (yeast) BUB1B BUB1 budding uninhibited by benzimidazoles 1 homolog beta (yeast) C9orf98 chromosome 9 open reading frame 98;C9orf98 CABC1 chaperone, ABC1 activity of bc1 complex like (S. pombe) CALM1 calmodulin 1 (phosphorylase kinase, delta) CALM2 calmodulin 2 (phosphorylase kinase, delta) CALM3 calmodulin 3 (phosphorylase kinase, delta) CAMK1 calcium/calmodulin-dependent protein kinase I CAMK2A calcium/calmodulin-dependent protein kinase (CaM kinase) II alpha CAMK2B calcium/calmodulin-dependent -
Supplementary Methods
SUPPLEMENTARY METHODS Epilepsy cohorts Epilepsy cohorts contributing to the meta-analysis are detailed below. EPIGEN (Reported by – Chantal Depondt, Sanjay Sisodiya, Norman Delanty, Gianpiero Cavalleri, Erin Heinzen and David Goldstein) The EPIGEN study consisted of epilepsy cohorts from Beaumont Hospital Dublin (Ireland), Université Libre de Bruxelles (ULB, Belgium), Duke University Medical Centre (North Carolina, USA) and University College Hospital London (UK). Inclusion Criteria: Except for Duke, only adult (>16 years) patients with epilepsy were recruited. Exclusion Criteria: No specific exclusion criteria. Quality assurance: At all sites, subjects were recruited and phenotyped by experienced epilepsy specialists. At Duke, all cases underwent independent case-record review by an epilepsy nurse specialist, and ambiguous diagnoses were re-evaluated by a second epileptologist. If the diagnosis remained unclear, then the patient was excluded from the study. For London, all cases underwent review by independent epileptologists. For Brussels, study PI (Chantal Depondt) reviewed the classification of all cases by case-note review. For Dublin, no systematic quality assurance was undertaken. Site-specific details for each EPIGEN cohort as organized for the analysis are as follows: – EPIGEN-Dublin Patients were recruited from a specialized epilepsy clinic at Beaumont Hospital, Dublin, Ireland. Patients were mostly of Irish ethnicity. Patients were genotyped on the Illumina platform using a combination of chips (610-Quad+550+300v1/Omni1-Quad). – EPIGEN-Brussels Patients were recruited from epilepsy clinics at UZ Gasthuisberg, Katholieke Universiteit Leuven, and Hôpital Erasme, Université Libre de Bruxelles. Patients were largely of Belgian ethnicity. Patients were genotyped on the Illumina platform using a combination of chips (610-Quad/300 V1 & V2). -
Genes Retina/RPE Choroid Sclera
Supplementary Materials: Genes Retina/RPE Choroid Sclera Fold Change p-value Fold Change p-value Fold Change p-value PPFIA2 NS NS 2.35 1.3X10-3 1.5 1.6X10-3 PTPRF 1.24 2.65X10-5 6.42 7X10-4 1.11 1X10-4 1.19 2.65X10-5 NS NS 1.11 3.3X10-3 PTPRR 1.44 2.65X10-5 3.04 4.7X10-3 NS NS Supplementary Table S1. Genes Differentially Expressed Related to Candidate Genes from Association. Genes selected for follow up validation by real time quantitative PCR. Multiple values for each gene indicate multiple probes within the same gene. NS indicates the fold change was not statistically significant. Gene/SNP Assay ID rs4764971 C__30866249_10 rs7134216 C__30023434_10 rs17306116 C__33218892_10 rs3803036 C__25749934_20 rs824311 C___8342112_10 PPFIA2 Hs00170308_m1 PTPRF Hs00160858_m1 PTPRR Hs00373136_m1 18S Hs03003631_g1 GAPDH Hs02758991_g1 Supplementary Table S2. Taqman® Genotyping and Gene Expression Assay Identification Numbers. SNP Chimp Orangutan Rhesus Marmoset Mouse Rat Cow Pig Guinea Pig Dog Elephant Opossum Chicken rs3803036 X X X X X X X X X X X X X rs1520562 X X X X X X rs1358228 X X X X X X X X X X X rs17306116 X X X X X X rs790436 X X X X X X X rs1558726 X X X X X X X X rs741525 X X X X X X X X rs7134216 X X X X X X rs4764971 X X X X X X X Supplementary Table S3. Conservation of Top SNPs from Association. X indicates SNP is conserved. -
Functional Genomics Analysis of Phelan-Mcdermid Syndrome 22Q13 Region During Human Neurodevelopment
Delft University of Technology Functional genomics analysis of Phelan-McDermid syndrome 22q13 region during human neurodevelopment Ziats, Catherine A.; Grosvenor, Luke P.; Sarasua, Sara M.; Thurm, Audrey E.; Swedo, Susan E.; Mahfouz, Ahmed; Rennert, Owen M.; Ziats, Mark N. DOI 10.1371/journal.pone.0213921 Publication date 2019 Document Version Final published version Published in PLoS ONE Citation (APA) Ziats, C. A., Grosvenor, L. P., Sarasua, S. M., Thurm, A. E., Swedo, S. E., Mahfouz, A., Rennert, O. M., & Ziats, M. N. (2019). Functional genomics analysis of Phelan-McDermid syndrome 22q13 region during human neurodevelopment. PLoS ONE, 14(3), 1-13. [e0213921]. https://doi.org/10.1371/journal.pone.0213921 Important note To cite this publication, please use the final published version (if applicable). Please check the document version above. Copyright Other than for strictly personal use, it is not permitted to download, forward or distribute the text or part of it, without the consent of the author(s) and/or copyright holder(s), unless the work is under an open content license such as Creative Commons. Takedown policy Please contact us and provide details if you believe this document breaches copyrights. We will remove access to the work immediately and investigate your claim. This work is downloaded from Delft University of Technology. For technical reasons the number of authors shown on this cover page is limited to a maximum of 10. RESEARCH ARTICLE Functional genomics analysis of Phelan- McDermid syndrome 22q13 region during human neurodevelopment 1☯ 2,3☯ 4 2 Catherine A. ZiatsID *, Luke P. Grosvenor , Sara M. Sarasua , Audrey E. -
A Computational Approach for Defining a Signature of Β-Cell Golgi Stress in Diabetes Mellitus
Page 1 of 781 Diabetes A Computational Approach for Defining a Signature of β-Cell Golgi Stress in Diabetes Mellitus Robert N. Bone1,6,7, Olufunmilola Oyebamiji2, Sayali Talware2, Sharmila Selvaraj2, Preethi Krishnan3,6, Farooq Syed1,6,7, Huanmei Wu2, Carmella Evans-Molina 1,3,4,5,6,7,8* Departments of 1Pediatrics, 3Medicine, 4Anatomy, Cell Biology & Physiology, 5Biochemistry & Molecular Biology, the 6Center for Diabetes & Metabolic Diseases, and the 7Herman B. Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN 46202; 2Department of BioHealth Informatics, Indiana University-Purdue University Indianapolis, Indianapolis, IN, 46202; 8Roudebush VA Medical Center, Indianapolis, IN 46202. *Corresponding Author(s): Carmella Evans-Molina, MD, PhD ([email protected]) Indiana University School of Medicine, 635 Barnhill Drive, MS 2031A, Indianapolis, IN 46202, Telephone: (317) 274-4145, Fax (317) 274-4107 Running Title: Golgi Stress Response in Diabetes Word Count: 4358 Number of Figures: 6 Keywords: Golgi apparatus stress, Islets, β cell, Type 1 diabetes, Type 2 diabetes 1 Diabetes Publish Ahead of Print, published online August 20, 2020 Diabetes Page 2 of 781 ABSTRACT The Golgi apparatus (GA) is an important site of insulin processing and granule maturation, but whether GA organelle dysfunction and GA stress are present in the diabetic β-cell has not been tested. We utilized an informatics-based approach to develop a transcriptional signature of β-cell GA stress using existing RNA sequencing and microarray datasets generated using human islets from donors with diabetes and islets where type 1(T1D) and type 2 diabetes (T2D) had been modeled ex vivo. To narrow our results to GA-specific genes, we applied a filter set of 1,030 genes accepted as GA associated. -
Datasheet Blank Template
SAN TA C RUZ BI OTEC HNOL OG Y, INC . MTMR3 (N-20): sc-47187 BACKGROUND RECOMMENDED SECONDARY REAGENTS Myotubularin and the myotubularin-related proteins (MTMR1-9) belong to a To ensure optimal results, the following support (secondary) reagents are highly conserved family of eukaryotic phosphatases. They are protein tyrosine recommended: 1) Western Blotting: use donkey anti-goat IgG-HRP: sc-2020 phosphatases that utilize inositol phospholipids, rather than phosphoproteins, (dilution range: 1:2000-1:100,000) or Cruz Marker™ compatible donkey as substrates. MTMR family members hydrolyze both Phosphatidylinositol anti- goat IgG-HRP: sc-2033 (dilution range: 1:2000-1:5000), Cruz Marker™ 3-phosphate (PtdIns3P) and PtdIns P2. MTMR2 interacts with MTMR5, an Molecular Weight Standards: sc-2035, TBS Blotto A Blocking Reagent: inactive family member that increases the enzymatic activity of MTMR2 and sc-2333 and Western Blotting Luminol Reagent: sc-2048. 2) Immunoprecip- dictates its subcellular localization. Mutations in MTMR2 cause autosomal itation: use Protein A/G PLUS-Agarose: sc-2003 (0.5 ml agarose/2.0 ml). recessive Charcot-Marie-Tooth type 4B1 (CMT4B1), which is characterized 3) Immunofluorescence: use donkey anti-goat IgG-FITC: sc-2024 (dilution by reduced nerve conduction velocities, focally folded myelin sheaths and range: 1:100-1:400) or donkey anti-goat IgG-TR: sc-2783 (dilution range: demyelination. MTMR3 and MTMR4 can either interact with each other or self 1:100-1:400) with UltraCruz™ Mounting Medium: sc-24941. associate. MTMR6 regulates the activity of the calcium-activated potassium channel 3.1. MTMR9 regulates the activity of MTMR7 and MTMR8. -
Functional Parsing of Driver Mutations in the Colorectal Cancer Genome Reveals Numerous Suppressors of Anchorage-Independent
Supplementary information Functional parsing of driver mutations in the colorectal cancer genome reveals numerous suppressors of anchorage-independent growth Ugur Eskiocak1, Sang Bum Kim1, Peter Ly1, Andres I. Roig1, Sebastian Biglione1, Kakajan Komurov2, Crystal Cornelius1, Woodring E. Wright1, Michael A. White1, and Jerry W. Shay1. 1Department of Cell Biology, University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, TX 75390-9039. 2Department of Systems Biology, University of Texas M.D. Anderson Cancer Center, Houston, TX 77054. Supplementary Figure S1. K-rasV12 expressing cells are resistant to p53 induced apoptosis. Whole-cell extracts from immortalized K-rasV12 or p53 down regulated HCECs were immunoblotted with p53 and its down-stream effectors after 10 Gy gamma-radiation. ! Supplementary Figure S2. Quantitative validation of selected shRNAs for their ability to enhance soft-agar growth of immortalized shTP53 expressing HCECs. Each bar represents 8 data points (quadruplicates from two separate experiments). Arrows denote shRNAs that failed to enhance anchorage-independent growth in a statistically significant manner. Enhancement for all other shRNAs were significant (two tailed Studentʼs t-test, compared to none, mean ± s.e.m., P<0.05)." ! Supplementary Figure S3. Ability of shRNAs to knockdown expression was demonstrated by A, immunoblotting for K-ras or B-E, Quantitative RT-PCR for ERICH1, PTPRU, SLC22A15 and SLC44A4 48 hours after transfection into 293FT cells. Two out of 23 tested shRNAs did not provide any knockdown. " ! Supplementary Figure S4. shRNAs against A, PTEN and B, NF1 do not enhance soft agar growth in HCECs without oncogenic manipulations (Student!s t-test, compared to none, mean ± s.e.m., ns= non-significant). -
Advancing a Clinically Relevant Perspective of the Clonal Nature of Cancer
Advancing a clinically relevant perspective of the clonal nature of cancer Christian Ruiza,b, Elizabeth Lenkiewicza, Lisa Eversa, Tara Holleya, Alex Robesona, Jeffrey Kieferc, Michael J. Demeurea,d, Michael A. Hollingsworthe, Michael Shenf, Donna Prunkardf, Peter S. Rabinovitchf, Tobias Zellwegerg, Spyro Moussesc, Jeffrey M. Trenta,h, John D. Carpteni, Lukas Bubendorfb, Daniel Von Hoffa,d, and Michael T. Barretta,1 aClinical Translational Research Division, Translational Genomics Research Institute, Scottsdale, AZ 85259; bInstitute for Pathology, University Hospital Basel, University of Basel, 4031 Basel, Switzerland; cGenetic Basis of Human Disease, Translational Genomics Research Institute, Phoenix, AZ 85004; dVirginia G. Piper Cancer Center, Scottsdale Healthcare, Scottsdale, AZ 85258; eEppley Institute for Research in Cancer and Allied Diseases, Nebraska Medical Center, Omaha, NE 68198; fDepartment of Pathology, University of Washington, Seattle, WA 98105; gDivision of Urology, St. Claraspital and University of Basel, 4058 Basel, Switzerland; hVan Andel Research Institute, Grand Rapids, MI 49503; and iIntegrated Cancer Genomics Division, Translational Genomics Research Institute, Phoenix, AZ 85004 Edited* by George F. Vande Woude, Van Andel Research Institute, Grand Rapids, MI, and approved June 10, 2011 (received for review March 11, 2011) Cancers frequently arise as a result of an acquired genomic insta- on the basis of morphology alone (8). Thus, the application of bility and the subsequent clonal evolution of neoplastic cells with purification methods such as laser capture microdissection does variable patterns of genetic aberrations. Thus, the presence and not resolve the complexities of many samples. A second approach behaviors of distinct clonal populations in each patient’s tumor is to passage tumor biopsies in tissue culture or in xenografts (4, 9– may underlie multiple clinical phenotypes in cancers. -
PDF Download
MEK-7 Polyclonal Antibody Catalog No : YT2725 Reactivity : Human,Mouse,Rat Applications : WB,ELISA Gene Name : MAP2K7 Protein Name : Dual specificity mitogen-activated protein kinase kinase 7 Human Gene Id : 5609 Human Swiss Prot O14733 No : Mouse Gene Id : 26400 Mouse Swiss Prot Q8CE90 No : Rat Gene Id : 363855 Rat Swiss Prot No : Q4KSH7 Immunogen : The antiserum was produced against synthesized peptide derived from human MAP2K7. AA range:241-290 Specificity : MEK-7 Polyclonal Antibody detects endogenous levels of MEK-7 protein. Formulation : Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide. Source : Rabbit Dilution : Western Blot: 1/500 - 1/2000. ELISA: 1/20000. Not yet tested in other applications. Purification : The antibody was affinity-purified from rabbit antiserum by affinity- chromatography using epitope-specific immunogen. Concentration : 1 mg/ml 1 / 3 Storage Stability : -20°C/1 year Molecularweight : 47485 Observed Band : 47 Cell Pathway : MAPK_ERK_Growth,MAPK_G_Protein,ErbB_HER,Toll_Like,T_Cell_Receptor, Fc epsilon RI,Neurotrophin,GnRH, Background : mitogen-activated protein kinase kinase 7(MAP2K7) Homo sapiens The protein encoded by this gene is a dual specificity protein kinase that belongs to the MAP kinase kinase family. This kinase specifically activates MAPK8/JNK1 and MAPK9/JNK2, and this kinase itself is phosphorylated and activated by MAP kinase kinase kinases including MAP3K1/MEKK1, MAP3K2/MEKK2,MAP3K3/MEKK5, and MAP4K2/GCK. This kinase is involved in the signal transduction mediating the cell -
Supplementary Figures 1-14 and Supplementary References
SUPPORTING INFORMATION Spatial Cross-Talk Between Oxidative Stress and DNA Replication in Human Fibroblasts Marko Radulovic,1,2 Noor O Baqader,1 Kai Stoeber,3† and Jasminka Godovac-Zimmermann1* 1Division of Medicine, University College London, Center for Nephrology, Royal Free Campus, Rowland Hill Street, London, NW3 2PF, UK. 2Insitute of Oncology and Radiology, Pasterova 14, 11000 Belgrade, Serbia 3Research Department of Pathology and UCL Cancer Institute, Rockefeller Building, University College London, University Street, London WC1E 6JJ, UK †Present Address: Shionogi Europe, 33 Kingsway, Holborn, London WC2B 6UF, UK TABLE OF CONTENTS 1. Supplementary Figures 1-14 and Supplementary References. Figure S-1. Network and joint spatial razor plot for 18 enzymes of glycolysis and the pentose phosphate shunt. Figure S-2. Correlation of SILAC ratios between OXS and OAC for proteins assigned to the SAME class. Figure S-3. Overlap matrix (r = 1) for groups of CORUM complexes containing 19 proteins of the 49-set. Figure S-4. Joint spatial razor plots for the Nop56p complex and FIB-associated complex involved in ribosome biogenesis. Figure S-5. Analysis of the response of emerin nuclear envelope complexes to OXS and OAC. Figure S-6. Joint spatial razor plots for the CCT protein folding complex, ATP synthase and V-Type ATPase. Figure S-7. Joint spatial razor plots showing changes in subcellular abundance and compartmental distribution for proteins annotated by GO to nucleocytoplasmic transport (GO:0006913). Figure S-8. Joint spatial razor plots showing changes in subcellular abundance and compartmental distribution for proteins annotated to endocytosis (GO:0006897). Figure S-9. Joint spatial razor plots for 401-set proteins annotated by GO to small GTPase mediated signal transduction (GO:0007264) and/or GTPase activity (GO:0003924). -
MAP3K12 (Human) Recombinant Protein
MAP3K12 (Human) Recombinant Gene Alias: DLK, MUK, ZPK, ZPKP1 Protein Gene Summary: The protein encoded by this gene is a member of serine/threonine protein kinase family. This Catalog Number: P5535 kinase contains a leucine-zipper domain, and is predominately expressed in neuronal cells. The Regulation Status: For research use only (RUO) phosphorylation state of this kinase in synaptic terminals Product Description: Human MAP3K12 (NP_006292.3, was shown to be regulated by membrane depolarization 1 a.a. - 520 a.a.) partial recombinant protein with GST via calcineurin. This kinase forms heterodimers with tag expressed in baculovirus infected Sf21 cells. leucine zipper containing transcription factors, such as cAMP responsive element binding protein (CREB) and Host: Insect MYC, and thus may play a regulatory role in PKA or retinoic acid induced neuronal differentiation. [provided Theoretical MW (kDa): 86 by RefSeq] Applications: Func, SDS-PAGE (See our web site product page for detailed applications information) Protocols: See our web site at http://www.abnova.com/support/protocols.asp or product page for detailed protocols Form: Liquid Preparation Method: Baculovirus infected insect cell (Sf21) expression system Purification: Glutathione sepharose chromatography Purity: 55 % by SDS-PAGE/CBB staining Activity: The activity was determined by ELISA. The enzyme was incubated with GST-fused substrate protein, and after stopping kinase reaction by EDTA, the reaction solution was transferred into glutathione-coated plate. Phosphorylation was detected by anti-phospho antibody and HRP-labeled anti-rabbit IgG (or HRP-labeled anti-mouse IgG). Substrate: MAP2K7 [inactive mutant]. ATP: 100 uM. Storage Buffer: In 50 mM Tris-HCl, 150 mM NaCl, pH 7.5 (0.1% CHAPS, 1 mM DTT, 10% glycerol) Storage Instruction: Store at -80°C.